Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 420

1.

Comparison of Real World and Core Laboratory Lupus Anticoagulant Results from the Antiphospholipid Syndrome (APS) ACTION Clinical Database and Repository.

Efthymiou M, Mackie IJ, Lane PJ, Andrade D, Willis R, Erkan D, Sciascia S, Krillis S, Bison E, Borges Galhardo Vendramini M, Romay-Penabad Z, Qi M, Tektonidou M, Ugarte A, Chighizola C, Belmont HM, Aguirre MA, Ji L, Branch DW, de Jesus G, Fortin PR, Andreoli L, Petri M, Cervera R, Rodriguez E, Knight JS, Atsumi T, Vega J, Ecem S, Bertolaccini ML, Pengo V, Cohen H; APS ACTION.

J Thromb Haemost. 2019 Jul 30. doi: 10.1111/jth.14596. [Epub ahead of print]

PMID:
31364274
2.

Effect of an additional neurosurgical resident on procedure length, operating room time, estimated blood loss, and post-operative length-of-stay.

Nguyen AV, Coggins WS, Jain RR, Branch DW, Allison RZ, Maynard K, Lall RR.

Br J Neurosurg. 2019 Jul 22:1-5. doi: 10.1080/02688697.2019.1642446. [Epub ahead of print]

PMID:
31328574
3.

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.

Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A, Meroni P, Ji L, Belmont HM, Cohen H, Ramires de Jesús G, Branch DW, Fortin PR, Andreoli L, Petri M, Rodriguez E, Rodriguez-Pinto I, Knight JS, Atsumi T, Willis R, Gonzalez E, Lopez-Pedrera R, Rossi Gandara AP, Borges Gualhardo Vendramini M, Banzato A, Sevim E, Barbhaiya M, Efthymiou M, Mackie I, Bertolaccini ML, Andrade D; APS ACTION.

Semin Arthritis Rheum. 2019 May 2. pii: S0049-0172(19)30090-3. doi: 10.1016/j.semarthrit.2019.04.009. [Epub ahead of print]

PMID:
31153708
4.

Cefazolin versus vancomycin for neurosurgical operative prophylaxis - A single institution retrospective cohort study.

Nguyen AV, Coggins WS, Jain RR, Branch DW, Allison RZ, Maynard K, Oliver B, Lall RR.

Clin Neurol Neurosurg. 2019 Jul;182:152-157. doi: 10.1016/j.clineuro.2019.05.017. Epub 2019 May 19.

PMID:
31129555
5.

Eluates from DAT-positive patients with or without hemolysis after high-dose IVIG yield predominantly IgG isoagglutinins of IgG2 subclass.

Yung GP, Seebach JD, Baerenzung N, Pendergrast J, Cserti-Gazdewich C, Branch DR.

Transfusion. 2019 May;59(5):1882-1883. doi: 10.1111/trf.15229. No abstract available.

PMID:
31050825
6.

Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy.

Hong S, Banchereau R, Maslow BL, Guerra MM, Cardenas J, Baisch J, Branch DW, Porter TF, Sawitzke A, Laskin CA, Buyon JP, Merrill J, Sammaritano LR, Petri M, Gatewood E, Cepika AM, Ohouo M, Obermoser G, Anguiano E, Kim TW, Nulsen J, Nehar-Belaid D, Blankenship D, Turner J, Banchereau J, Salmon JE, Pascual V.

J Exp Med. 2019 May 6;216(5):1154-1169. doi: 10.1084/jem.20190185. Epub 2019 Apr 8.

PMID:
30962246
7.

A GYPB variant encoding an altered leader peptide leads to a weak S phenotype.

Cote J, Cen S, Fennell K, Pambrun C, Branch DR, Ochoa-Garay G.

Transfusion. 2019 Jul;59(7):2461-2462. doi: 10.1111/trf.15295. Epub 2019 Mar 30. No abstract available.

PMID:
30927367
8.
9.

Metabolic Syndrome Associated with Increased Rates of Medical Complications After Intracranial Tumor Resection.

Nia AM, Branch DW, Maynard K, Frank T, Zavlin D, Patterson JT, Lall RR.

World Neurosurg. 2019 Mar 13. pii: S1878-8750(19)30673-4. doi: 10.1016/j.wneu.2019.03.046. [Epub ahead of print]

PMID:
30878753
10.

Immunotherapy: the good, the bad, the ugly, and the really ugly.

Branch DR.

Transfusion. 2019 Feb;59(2):437-440. doi: 10.1111/trf.15142. No abstract available.

PMID:
30727039
11.

The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.

Sciascia S, Willis R, Pengo V, Krilis S, Andrade D, Tektonidou MG, Ugarte A, Chighizola C, Branch DW, Levy RA, Nalli C, Fortin PR, Petri M, Rodriguez E, Rodriguez-Pinto I, Atsumi T, Nascimento I, Rosa R, Banzato A, Erkan D, Cohen H, Efthymiou M, Mackie I, Bertolaccini ML; APS ACTION.

Thromb Res. 2019 Mar;175:32-36. doi: 10.1016/j.thromres.2019.01.010. Epub 2019 Jan 18.

PMID:
30685523
12.

The expected labor progression after labor augmentation with oxytocin: A retrospective cohort study.

Zhang L, Troendle J, Branch DW, Hoffman M, Yu J, Zhou L, Duan T, Zhang J.

PLoS One. 2018 Oct 31;13(10):e0205735. doi: 10.1371/journal.pone.0205735. eCollection 2018.

13.

The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2.

Lemay AS, Tong TN, Branch DR, Huang M, Sumner C, Oldfield L, Hawes J, Cserti-Gazdewich CM, Lau W.

Transfusion. 2018 Nov;58(11):2506-2512. doi: 10.1111/trf.14867. Epub 2018 Oct 9.

PMID:
30299537
14.

Surgical Management of Placenta Accreta Spectrum.

Einerson BD, Branch DW.

Clin Obstet Gynecol. 2018 Dec;61(4):774-782. doi: 10.1097/GRF.0000000000000406. Review.

PMID:
30299279
15.

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.

de Jesús GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA; APS ACTION.

BJOG. 2019 Apr;126(5):656-661. doi: 10.1111/1471-0528.15469. Epub 2018 Oct 24.

PMID:
30222236
16.

The Monocyte Monolayer Assay: Past, Present and Future.

Tong TN, Cen S, Branch DR.

Transfus Med Rev. 2019 Jan;33(1):24-28. doi: 10.1016/j.tmrv.2018.07.004. Epub 2018 Aug 8. Review.

PMID:
30139679
17.

Antiphospholipid antibodies in women with severe preeclampsia and placental insufficiency: a case-control study.

Gibbins KJ, Tebo AE, Nielsen SK, Branch DW.

Lupus. 2018 Oct;27(12):1903-1910. doi: 10.1177/0961203318787035. Epub 2018 Jul 20.

PMID:
30028257
18.

Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.

Yelnik CM, Lambert M, Drumez E, Le Guern V, Bacri JL, Guerra MM, Laskin CA, Branch DW, Sammaritano LR, Morel N, Guettrot-Imbert G, Launay D, Hachulla E, Hatron PY, Salmon JE, Costedoat-Chalumeau N.

Lupus. 2018 Sep;27(10):1679-1686. doi: 10.1177/0961203318787032. Epub 2018 Jul 17.

PMID:
30016929
19.

GPIbα is required for platelet-mediated hepatic thrombopoietin generation.

Xu M, Li J, Neves MAD, Zhu G, Carrim N, Yu R, Gupta S, Marshall J, Rotstein O, Peng J, Hou M, Kunishima S, Ware J, Branch DR, Lazarus AH, Ruggeri ZM, Freedman J, Ni H.

Blood. 2018 Aug 9;132(6):622-634. doi: 10.1182/blood-2017-12-820779. Epub 2018 May 24.

20.

Preconception antiphospholipid antibodies and risk of subsequent early pregnancy loss.

Gibbins KJ, Mumford SL, Sjaarda LA, Branch DW, Perkins NJ, Ye A, Schisterman EF, Silver RM.

Lupus. 2018 Aug;27(9):1437-1445. doi: 10.1177/0961203318776089. Epub 2018 May 17.

21.

Evaluation of the functional properties of cryopreserved buffy coat-derived monocytes for monocyte monolayer assay.

Kipkeu BJ, Shyian ML, da Silveira Cavalcante L, Duong TT, Yeung RSM, Binnington B, Branch DR, Acker JP, Holovati JL.

Transfusion. 2018 Aug;58(8):2027-2035. doi: 10.1111/trf.14650. Epub 2018 May 9.

PMID:
29744883
22.

GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out.

Lewis BJB, Leontyev D, Neschadim A, Blacquiere M, Branch DR.

Clin Exp Immunol. 2018 Sep;193(3):293-301. doi: 10.1111/cei.13144.

PMID:
29704458
23.

Red blood cells, still vital after all these years: Commentary on Canadian Blood Services' International Symposium 2017.

Qadri SM, Donkor DA, Yan M, Ning S, Branch DR, Seghatchian J, Sheffield WP.

Transfus Apher Sci. 2018 Apr;57(2):298-303. doi: 10.1016/j.transci.2018.04.011. Epub 2018 Apr 19. Review.

PMID:
29691151
24.

The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.

Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A, Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi T, Willis R, Zuily S, Tektonidou MG; AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Investigators.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):134-141. doi: 10.1002/acr.23584.

PMID:
29669399
25.

Placenta Accreta Spectrum.

Silver RM, Branch DW.

N Engl J Med. 2018 Apr 19;378(16):1529-1536. doi: 10.1056/NEJMcp1709324. Review. No abstract available.

PMID:
29669225
26.

Performance Evaluation and Clinical Associations of Immunoassays That Detect Antibodies to Negatively Charged Phospholipids Other Than Cardiolipin.

Castanon A, Pierre G, Willis R, Harris EN, Papalardo E, Romay-Penabad Z, Schleh A, Jajoria P, Smikle M, DeCeulaer K, Tebo A, Jaskowski T, Guerra MM, Branch DW, Salmon JE, Petri M, Gonzalez EB.

Am J Clin Pathol. 2018 Mar 29;149(5):401-411. doi: 10.1093/ajcp/aqy003.

27.

rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs.

Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Käsermann F, Zuercher AW.

J Immunol. 2018 Apr 15;200(8):2542-2553. doi: 10.4049/jimmunol.1701171. Epub 2018 Mar 12.

28.

Bacterial neuraminidase-mediated erythrocyte desialylation provokes cell surface aminophospholipid exposure.

Qadri SM, Donkor DA, Nazy I, Branch DR, Sheffield WP.

Eur J Haematol. 2018 May;100(5):502-510. doi: 10.1111/ejh.13047. Epub 2018 Mar 30.

PMID:
29453885
29.

Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.

Kim MY, Guerra MM, Kaplowitz E, Laskin CA, Petri M, Branch DW, Lockshin MD, Sammaritano LR, Merrill JT, Porter TF, Sawitzke A, Lynch AM, Buyon JP, Salmon JE.

Ann Rheum Dis. 2018 Apr;77(4):549-555. doi: 10.1136/annrheumdis-2017-212224. Epub 2018 Jan 25.

30.

ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis.

Branch DR, Hellberg Å, Bruggeman CW, Storry JR, Sakac D, Blacquiere M, Tong TN, Burke-Murphy E, Binnington B, Parmar N, Riden LS, Willie K, Armali C, Aziz J, Lieberman L, Laroche V, Callum J, Lin Y, Shehata N, Pavenski K, Lau W, Hannach B, Kuijpers TW, Olsson ML, Cserti-Gazdewich C, Pendergrast J.

Blood. 2018 Feb 15;131(7):830-835. doi: 10.1182/blood-2017-07-796151. Epub 2018 Jan 5. No abstract available.

31.

Cervical Pessary to Prevent Preterm Birth.

Silver RM, Branch DW.

JAMA. 2017 Dec 19;318(23):2299-2300. doi: 10.1001/jama.2017.18955. No abstract available.

PMID:
29260206
32.

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.

Erkan D, Unlu O, Sciascia S, Belmont HM, Branch DW, Cuadrado MJ, Gonzalez E, Knight JS, Uthman I, Willis R, Zhang Z, Wahl D, Zuily S, Tektonidou MG; APS ACTION.

Lupus. 2018 Mar;27(3):399-406. doi: 10.1177/0961203317724219. Epub 2017 Aug 1.

PMID:
28764618
33.

Rapid Nucleic Acid Extraction and Purification Using a Miniature Ultrasonic Technique.

Branch DW, Vreeland EC, McClain JL, Murton JK, James CD, Achyuthan KE.

Micromachines (Basel). 2017 Jul 21;8(7). pii: E228. doi: 10.3390/mi8070228.

34.

Reproductive rights advocacy: not just for the family-planning community.

Heuser CC, Gibbins KJ, Smid MC, Branch DW.

Am J Obstet Gynecol. 2017 Sep;217(3):322.e1-322.e4. doi: 10.1016/j.ajog.2017.06.006. Epub 2017 Jun 10.

35.

Mechanism of graphene-induced cytotoxicity: Role of endonucleases.

Fahmi T, Branch D, Nima ZA, Jang DS, Savenka AV, Biris AS, Basnakian AG.

J Appl Toxicol. 2017 Nov;37(11):1325-1332. doi: 10.1002/jat.3462. Epub 2017 May 24.

PMID:
28543094
36.

Microsurgical Removal of Microcatheter in the Middle Cerebral Artery During Resection of an Arteriovenous Malformation Resection.

Shazadeh Safavi P, Desai S, Branch D, Ortega-Barnett JR.

Cureus. 2017 Apr 13;9(4):e1164. doi: 10.7759/cureus.1164.

37.

Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.

Kaplowitz ET, Ferguson S, Guerra M, Laskin CA, Buyon JP, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Merrill JT, Katz P, Salmon JE.

Arthritis Care Res (Hoboken). 2018 Feb;70(2):230-235. doi: 10.1002/acr.23263. Epub 2017 Dec 29.

38.

IVIG regulates the survival of human but not mouse neutrophils.

Schneider C, Wicki S, Graeter S, Timcheva TM, Keller CW, Quast I, Leontyev D, Djoumerska-Alexieva IK, Käsermann F, Jakob SM, Dimitrova PA, Branch DR, Cummings RD, Lünemann JD, Kaufmann T, Simon HU, von Gunten S.

Sci Rep. 2017 May 2;7(1):1296. doi: 10.1038/s41598-017-01404-0.

39.

Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.

Buyon JP, Kim MY, Guerra MM, Lu S, Reeves E, Petri M, Laskin CA, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Salmon JE.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):940-946. doi: 10.2215/CJN.11431116. Epub 2017 Apr 11.

40.

The immune-stimulation capacity of liposome-treated red blood cells.

da Silveira Cavalcante L, Branch DR, Duong TT, Yeung RSM, Acker JP, Holovati JL.

J Liposome Res. 2018 Sep;28(3):173-181. doi: 10.1080/08982104.2017.1295991. Epub 2017 Mar 9.

PMID:
28276279
41.

Use of a Monocyte Monolayer Assay to Evaluate Fcγ Receptor-mediated Phagocytosis.

Tong TN, Branch DR.

J Vis Exp. 2017 Jan 2;(119). doi: 10.3791/55039.

42.

Ebola virus VP35 blocks stress granule assembly.

Le Sage V, Cinti A, McCarthy S, Amorim R, Rao S, Daino GL, Tramontano E, Branch DR, Mouland AJ.

Virology. 2017 Feb;502:73-83. doi: 10.1016/j.virol.2016.12.012. Epub 2016 Dec 23.

43.

Shining a light on AHG "blind" spot(s).

Branch DR, Westhoff CM.

Transfusion. 2016 Dec;56(12):2913-2915. doi: 10.1111/trf.13921. No abstract available.

PMID:
27933617
44.

Stillbirth: the impact of antiphospholipid syndrome?

Herrera CA, Heuser CC, Branch DW.

Lupus. 2017 Mar;26(3):237-239. doi: 10.1177/0961203316671815. Epub 2016 Oct 3.

PMID:
27698076
45.

Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice.

Liu J, Santhanakrishnan M, Natarajan P, Gibb DR, Eisenbarth SC, Tormey CA, Siddon AJ, Stowell SR, Branch DR, Hendrickson JE.

Blood. 2016 Dec 29;128(26):3159-3168. doi: 10.1182/blood-2016-06-724732. Epub 2016 Sep 29.

46.

Optimal conditions for the performance of a monocyte monolayer assay.

Tong TN, Burke-Murphy E, Sakac D, Pendergrast J, Cserti-Gazdewich C, Laroche V, Branch DR.

Transfusion. 2016 Nov;56(11):2680-2690. doi: 10.1111/trf.13766. Epub 2016 Aug 21.

PMID:
27546234
47.

Recurrent Pregnancy Loss: Generally Accepted Causes and Their Management.

Kaiser J, Branch DW.

Clin Obstet Gynecol. 2016 Sep;59(3):464-73. doi: 10.1097/GRF.0000000000000214. Review.

PMID:
27455203
48.

Practical Work-up and Management of Recurrent Pregnancy Loss for the Front-Line Clinician.

Branch DW, Silver RM.

Clin Obstet Gynecol. 2016 Sep;59(3):535-8. doi: 10.1097/GRF.0000000000000216. Review.

PMID:
27403584
49.

Foreword.

Silver RM, Branch DW, Porter TF.

Clin Obstet Gynecol. 2016 Sep;59(3):455. doi: 10.1097/GRF.0000000000000220. No abstract available.

PMID:
27403583
50.

Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus.

Tebo AE, Willis R, Jaskowski TD, Guerra M, Pierangeli SS, Salmon J, Petri M, Branch DW.

Clin Chim Acta. 2016 Sep 1;460:107-13. doi: 10.1016/j.cca.2016.06.025. Epub 2016 Jun 23.

PMID:
27346478

Supplemental Content

Loading ...
Support Center